Episode 24: The Rules Have Changed: Decentralized Clinical Trials for Drugs
Reproductive Health: Over the Counter Birth Control Pill Supported by FDA Advisory Committees
Gender Affirming Care Restricted Under Missouri Bill
FDA and SAMHSA Issue Joint Statement in Support of Reducing Barriers to Evidence Based Treatments
Software as a Medical Device: Challenges Facing the Industry
FDA’s New Guidance Proposes Flexible Use of AI in Medical Devices
DEA Extends Telemedicine Flexibilities for Prescribing of Controlled Medications
Florida’s Bill Targeting Gender Affirming Care Impacts Minors and Adults
FDA Encourages the Use of Decentralized Clinical Trials in New Draft Guidance
Subscribe: Subscribe via RSS